Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Adam Hickey"'
Autor:
Louise Emmett, Nikeith John, Sarennya Pathmanandavel, William Counter, Maria Ayers, Shikha Sharma, Shikha Agrawal, Aron Poole, Elizabeth Hovey, Ganes Pranavan, Craig Gedye, Girish Mallesara, Alex Guminski, Adrian Lee, Martin R. Stockler, Adam Hickey, Peter Eu, Anthony M. Joshua, Megan Crumbaker, Andrew Nguyen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: 177 LuPSMA is an effective treatment in metastatic castrate-resistant prostate cancer with trials adopting a standardised dose interval. Adjusting treatment intervals utilising early response biomarkers may improve patient outcomes. Objec
Externí odkaz:
https://doaj.org/article/ac05d1fb3eb0484885744861a7656b88
Autor:
Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, William Counter, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Aron Poole, Adam Hickey, Shikha Agrawal, Gary Perkins, Annukka Kallinen, Enid Eslick, Martin R. Stockler, Anthony M. Joshua, Andrew Nguyen, Louise Emmett
Publikováno v:
Journal of Nuclear Medicine. 64:410-415
Autor:
Sarennya Pathmanandavel, Megan Crumbaker, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Adam Hickey, Peter Eu, Martin Stockler, Andrew J. Martin, Anthony M. Joshua, Andrew Nguyen, Louise Emmett
Publikováno v:
Journal of Nuclear Medicine. 64:221-226
Autor:
Rachel Dear, Louise Emmett, Elgene Lim, Joanne Keane, Adam Hickey, Julia Chen, Bao Ho, Gemma Sheehan-Dare, Reuben Tang, Andrew Chen, Andrew Nguyen, Lyn Chan, Karen Fullard, Rohan Nandurkar
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 66:731-737
Introduction 18 F-Fludeoxyglucose PET-CT (FDG) is increasingly used to stage breast cancer. Most breast cancers express the Oestrogen Receptor (ER) and Progesterone Receptor (PR), and this subtype demonstrates lower activity on FDG imaging. Somatosta
Autor:
Sarennya, Pathmanandavel, Megan, Crumbaker, Bao, Ho, Andrew O, Yam, Peter, Wilson, Remy, Niman, Maria, Ayers, Shikha, Sharma, Adam, Hickey, Peter, Eu, Martin, Stockler, Andrew J, Martin, Anthony M, Joshua, Andrew, Nguyen, Louise, Emmett
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Autor:
Venu Chalasani, Richard J. Epstein, Noah Ihsheish, Charlotte Yin, Megan Crumbaker, Gordon F. O'Neill, Anthony M. Joshua, George Hruby, Lisa G. Horvath, Adam Hickey, Andrew Kneebone, Quoc Nguyen, Phillip D. Stricker, Louise Emmett
Publikováno v:
Journal of Nuclear Medicine. 60:950-954
Prostate-specific membrane antigen (PSMA) may be targeted for both diagnostic and therapeutic purposes in the management of prostate cancer (PCa). In preclinical models, androgen blockade (AB) increases expression of PSMA in both hormone-sensitive an
Autor:
Andrew, Nguyen, Karen, Fullard, Gemma, Sheehan-Dare, Reuben, Tang, Lyn, Chan, Bao, Ho, Rachel, Dear, Joanne, Keane, Adam, Hickey, Rohan, Nandurkar, Julia, Chen, Andrew, Chen, Elgene, Lim, Louise, Emmett
Publikováno v:
Journal of medical imaging and radiation oncologyReferences. 66(6)
Patients with clinically progressive metastatic ERTen women (mean age 57 years) underwent imaging. 8/10 demonstrated disease on both DOTA and FDG. 2/10 positive on conventional imaging, but DOTAWhilst we have not demonstrated DOTA to be superior to F
Autor:
Rohan Nandurkar, Louise Emmett, Pimmeke van Leeuwen, Carlo Yuen, Adam Hickey, Henry H. Woo, David Ende, Thomas Cusick, Phillip D. Stricker, Rajdeep Kooner, Bao Ho, Gordon F. O'Neill
Publikováno v:
British Journal of Radiology, 92(1095):20180667. British Institute of Radiology
To determine the predictive and diagnostic value of (68)Ga-HBEDD PSMA-11 positron emission tomography (PET)/CT (prostate-specific membrane antigen, PSMA) for surgical response in males with prostate cancer prior to radical prostatectomy. METHODS: We
Autor:
Louise, Emmett, Charlotte, Yin, Megan, Crumbaker, George, Hruby, Andrew, Kneebone, Richard, Epstein, Quoc, Nguyen, Adam, Hickey, Noah, Ihsheish, Gordon, O'Neill, Lisa, Horvath, Venu, Chalasani, Phillip, Stricker, Anthony M, Joshua
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60(7)
Prostate-specific membrane antigen (PSMA) may be targeted for both diagnostic and therapeutic purposes in the management of prostate cancer (PCa). In preclinical models, androgen blockade (AB) increases expression of PSMA in both hormone-sensitive an
Autor:
Megan Crumbaker, Louise Emmett, Andrew O. Yam, Lalith Ratnayake, Wai Ling Chan, Andrew Nguyen, Edmond M. Kwan, Anthony M. Joshua, Arun Azad, Peter Eu, Shikha Sharma, Christopher Rofe, Bao Ho, Kamonwan Kongrak, Adam Hickey, Sarennya Pathmanandavel
Publikováno v:
Journal of Clinical Oncology. 39:103-103
103 Background: 177LuPSMA – 617 is a promising therapy for metastatic castrate-resistant prostate cancer (mCRPC). However, treatment resistance occurs frequently and synergistic combination therapy may improve outcomes. We combined 177LuPSMA – 61